New XARELTO ® (rivaroxaban) Peripheral Artery Disease (PAD) Data from EXPLORER Clinical Research Program to be Unveiled at American Heart Association (AHA) Scientific Sessions 2020
RARITAN, N.J., November 9, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that 10 data presentations will be shared at the virtual American Heart Association (AHA) Scientific Sessions 2020 from November 13-17. Most notably, four new sub-analyses of XARELTO® (rivaroxaban) from the landmark VOYAGER PAD trial, part of the EXPLORER global cardiovascular research program, will be presented, including two live, featured science oral presentations. “We're pleased VOYAGER PAD was selected to be front and center once again at a major medical congress, as there's an urgent need for data in ...
Source: Johnson and Johnson - November 9, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news
DNA BIOPHARM ® Leads National Bladder Awareness Month Initiatives...
New Women’s Urinary Incontinence Supplement, FEMAXEEN®, sheds light on bladder health(PRWeb November 06, 2020)Read the full story at https://www.prweb.com/releases/dna_biopharm_leads_national_bladder_awareness_month_initiatives_tied_to_femaxeen/prweb17529442.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 6, 2020 Category: Pharmaceuticals Source Type: news
Higher risk of future fecal incontinence after sphincter injuries
(University of Gothenburg) The risk of subsequent fecal incontinence and intestinal gas leakage is significantly higher among women who, during childbirth, have suffered a sphincter injury and consequent damage to the anal sphincter muscle, was shown in a new study from the University of Gothenburg. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - November 2, 2020 Category: International Medicine & Public Health Source Type: news
Janssen Submits Application to U.S. FDA for New Indication to Expand Use of XARELTO ® (rivaroxaban) in Patients with Peripheral Artery Disease
RARITAN, NJ, October 26, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for a new indication to expand the use of XARELTO® (rivaroxaban) in patients with peripheral artery disease (PAD). If approved, this new indication for the XARELTO® vascular dose (2.5 mg twice daily plus aspirin 75-100 mg once daily) would include reducing the risk of major thrombotic vascular events such as heart attack, stroke and amputation in patients after recent lower-extremity revascularization, a c...
Source: Johnson and Johnson - October 26, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news
$1.6 Million grant to reverse urinary incontinence
(University of Houston) With a $1.6 million grant, a University of Houston researcher is working to reverse pelvic floor dysfunction which can result in urinary incontinence, a condition affecting 30-60% of the female population and 5-15% of males. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - October 15, 2020 Category: International Medicine & Public Health Source Type: news
Kegels: Underused by women to treat and prevent urinary incontinence
(Mary Ann Liebert, Inc./Genetic Engineering News) Kegels are underused to treat and prevent urinary incontinence, especially during pregnancy and the postpartum period. This woman-controlled, non-invasive muscle exercise should be taught and the use of Kegels encouraged by providers (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 13, 2020 Category: International Medicine & Public Health Source Type: news
Medtronic Announces First Patient Implanted in ELITE Study of InterStim(TM) Micro
ELITE is the Only Study of a Rechargeable Sacral Neurostimulation System to Include All Four Indications, Including Fecal Incontinence, Which Affects Millions
DUBLIN, Oct. 6, 2020 -- (Healthcare Sales & Marketing Network) -- Medtronic plc (NYSE:MDT), t... Devices, Urology Medtronic, InterStim Micro, sacral neurostimulation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 6, 2020 Category: Pharmaceuticals Source Type: news
Mayo Clinic Q and A: Pregnancy and prolapse concerns
DEAR MAYO CLINIC: I am seven months pregnant with my first child. My obstetrician said I have ureterocele. He also mentioned bladder prolapse. I am not having incontinence at the moment, but I have a lot of pain and always feel like I'm on the verge of an accident. I am trying to understand the [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 17, 2020 Category: Databases & Libraries Source Type: news
Common class of drugs linked to increased risk of Alzheimer's disease
(University of California - San Diego) UC San Diego researchers report that a class of drugs used for a broad array of conditions, from allergies and colds to hypertension and urinary incontinence, may be associated with an increased risk of cognitive decline, particularly in older adults at greater risk for Alzheimer's disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 4, 2020 Category: International Medicine & Public Health Source Type: news
Magnetic stimulation dramatically improves fecal incontinence
(Medical College of Georgia at Augusta University) Painless magnetic stimulation of nerves that regulate muscles in the anus and rectum appears to improve their function and dramatically reduce episodes of fecal incontinence, a debilitating problem affecting about 10% of the population, investigators report. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - August 25, 2020 Category: International Medicine & Public Health Source Type: news
Fixed or Adjustable Sling for Stress Urinary Incontinence Fixed or Adjustable Sling for Stress Urinary Incontinence
What are the advantages of each of these types of male slings for stress urinary incontinence -- and how do they differ?Translational Andrology and Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 24, 2020 Category: Consumer Health News Tags: Urology Journal Article Source Type: news
Botox Injections May Ease Depression
MONDAY, Aug. 3, 2020 -- Botox injections, which are commonly used to lessen wrinkles, migraines, muscle spasms, excessive sweating, and incontinence, may also help treat depression, according to a study published online July 30 in Scientific... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 3, 2020 Category: Pharmaceuticals Source Type: news
Vaginal mesh implant: What is the ‘scandal’ and are you entitled to make a claim?
VAGINAL mesh implants were introduced in 1998 as a quick and easy way to treat stress urinary incontinence and pelvic organ prolapse in women, particular after childbirth. But the surgery has been found to be life-changing and sometimes irreversible. Could you be entitled to compensation? (Source: Daily Express - Health)
Source: Daily Express - Health - July 20, 2020 Category: Consumer Health News Source Type: news
Tension-Free Tape Repair May Boost Sexual Function Related to Stress Incontinence Tension-Free Tape Repair May Boost Sexual Function Related to Stress Incontinence
Slingplasty with tension-free vaginal tape improved sexual function in women with stress urinary incontinence in a study in China. Sexual function improved in 77% of women and was unchanged in 17%.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 16, 2020 Category: Consumer Health News Tags: Urology News Source Type: news
Will victims of mesh scandal be betrayed all over again? Baroness warns against report being ignored
Since 2011, Good Health has been telling the stories of women whose lives had been devastated by problems with the plastic tension-free vaginal tape (TVT) inserted to treat incontinence and prolapse. (Source: the Mail online | Health)
Source: the Mail online | Health - July 14, 2020 Category: Consumer Health News Source Type: news
